See more section
A trusted advisor with extensive knowledge of the pharmaceutical industry, Herschel counsels clients on all aspects of pharmaceutical asset acquisitions, licensing, clinical and preclinical drug development, and commercialization. He also has provided corporate, mergers and acquisitions, and other transactional representation to a wide variety of publicly held and private enterprises.
Herschel brings a tremendous understanding of the needs of pharmaceutical clients to his work at Lowenstein Sandler. Prior to joining the firm, he was Senior Vice President, General Counsel, and Secretary at Forest Laboratories, a U.S.-based specialty pharmaceutical company with more than $4 billion in annual revenues. As General Counsel, Herschel was responsible for significant licensing, collaboration and acquisition transactions, all litigation and regulatory proceedings, responses to major proxy challenges, and legal support for all functions of the organization. In addition, he led the company's response to various governmental and other investigations, and participated in the development of a robust health care law and regulation compliance program.